Literature DB >> 8668204

Analysis of functional domain organization in DNA topoisomerase II from humans and Saccharomyces cerevisiae.

S Jensen1, A H Andersen, E Kjeldsen, H Biersack, E H Olsen, T B Andersen, O Westergaard, B K Jakobsen.   

Abstract

The functional domain structure of human DNA topoisomerase IIalpha and Saccharomyces cerevisiae DNA topoisomerase II was studied by investigating the abilities of insertion and deletion mutant enzymes to support mitotic growth and catalyze transitions in DNA topology in vitro. Alignment of the human topoisomerase IIalpha and S. cerevisiae topoisomerase II sequences defined 13 conserved regions separated by less conserved or differently spaced sequences. The spatial tolerance of the spacer regions was addressed by insertion of linkers. The importance of the conserved regions was assessed through deletion of individual domains. We found that the exact spacing between most of the conserved domains is noncritical, as insertions in the spacer regions were tolerated with no influence on complementation ability. All conserved domains, however, are essential for sustained mitotic growth of S. cerevisiae and for enzymatic activity in vitro. A series of topoisomerase II carboxy-terminal truncations were investigated with respect to the ability to support viability, cellular localization, and enzymatic properties. The analysis showed that the divergent carboxy-terminal region of human topoisomerase IIalpha is dispensable for catalytic activity but contains elements that specifically locate the protein to the nucleus.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8668204      PMCID: PMC231383          DOI: 10.1128/MCB.16.7.3866

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  68 in total

Review 1.  Biochemical basis for the interactions of type I and type II topoisomerases with DNA.

Authors:  N Osheroff
Journal:  Pharmacol Ther       Date:  1989       Impact factor: 12.310

2.  Illegitimate recombination mediated by calf thymus DNA topoisomerase II in vitro.

Authors:  Y S Bae; I Kawasaki; H Ikeda; L F Liu
Journal:  Proc Natl Acad Sci U S A       Date:  1988-04       Impact factor: 11.205

3.  A consensus sequence for cleavage by vertebrate DNA topoisomerase II.

Authors:  J R Spitzner; M T Muller
Journal:  Nucleic Acids Res       Date:  1988-06-24       Impact factor: 16.971

4.  Swiveling and decatenation of replicating simian virus 40 genomes in vivo.

Authors:  R M Snapka; M A Powelson; J M Strayer
Journal:  Mol Cell Biol       Date:  1988-02       Impact factor: 4.272

5.  Sgs1: a eukaryotic homolog of E. coli RecQ that interacts with topoisomerase II in vivo and is required for faithful chromosome segregation.

Authors:  P M Watt; E J Louis; R H Borts; I D Hickson
Journal:  Cell       Date:  1995-04-21       Impact factor: 41.582

6.  Structure and mechanism of DNA topoisomerase II.

Authors:  J M Berger; S J Gamblin; S C Harrison; J C Wang
Journal:  Nature       Date:  1996-01-18       Impact factor: 49.962

Review 7.  DNA topoisomerase II mutations and resistance to anti-tumor drugs.

Authors:  Y S Vassetzky; G C Alghisi; S M Gasser
Journal:  Bioessays       Date:  1995-09       Impact factor: 4.345

8.  Phosphorylation of DNA topoisomerase II in vivo and in total homogenates of Drosophila Kc cells. The role of casein kinase II.

Authors:  P Ackerman; C V Glover; N Osheroff
Journal:  J Biol Chem       Date:  1988-09-05       Impact factor: 5.157

9.  Expression, domain structure, and enzymatic properties of an active recombinant human DNA topoisomerase II beta.

Authors:  C A Austin; K L Marsh; R A Wasserman; E Willmore; P J Sayer; J C Wang; L M Fisher
Journal:  J Biol Chem       Date:  1995-06-30       Impact factor: 5.157

10.  A system of shuttle vectors and yeast host strains designed for efficient manipulation of DNA in Saccharomyces cerevisiae.

Authors:  R S Sikorski; P Hieter
Journal:  Genetics       Date:  1989-05       Impact factor: 4.562

View more
  18 in total

1.  Cellular distribution of mammalian DNA topoisomerase II is determined by its catalytically dispensable C-terminal domain.

Authors:  N Adachi; M Miyaike; S Kato; R Kanamaru; H Koyama; A Kikuchi
Journal:  Nucleic Acids Res       Date:  1997-08-01       Impact factor: 16.971

2.  Impact of the C-terminal domain of topoisomerase IIalpha on the DNA cleavage activity of the human enzyme.

Authors:  Jennifer S Dickey; Neil Osheroff
Journal:  Biochemistry       Date:  2005-08-30       Impact factor: 3.162

Review 3.  The use of divalent metal ions by type II topoisomerases.

Authors:  Joseph E Deweese; Neil Osheroff
Journal:  Metallomics       Date:  2010-05-21       Impact factor: 4.526

4.  cin-4, a gene with homology to topoisomerase II, is required for centromere resolution by cohesin removal from sister kinetochores during mitosis.

Authors:  Gerald Stanvitch; Landon L Moore
Journal:  Genetics       Date:  2008-01       Impact factor: 4.562

5.  Bimodal recognition of DNA geometry by human topoisomerase II alpha: preferential relaxation of positively supercoiled DNA requires elements in the C-terminal domain.

Authors:  A Kathleen McClendon; Amanda C Gentry; Jennifer S Dickey; Marie Brinch; Simon Bendsen; Anni H Andersen; Neil Osheroff
Journal:  Biochemistry       Date:  2008-12-16       Impact factor: 3.162

6.  Modulation of drug sensitivity in yeast cells by the ATP-binding domain of human DNA topoisomerase IIalpha.

Authors:  Nathalie Vilain; Monika Tsai-Pflugfelder; Audrey Benoit; Susan M Gasser; Didier Leroy
Journal:  Nucleic Acids Res       Date:  2003-10-01       Impact factor: 16.971

7.  Chiral discrimination and writhe-dependent relaxation mechanism of human topoisomerase IIα.

Authors:  Yeonee Seol; Amanda C Gentry; Neil Osheroff; Keir C Neuman
Journal:  J Biol Chem       Date:  2013-03-18       Impact factor: 5.157

8.  Functional dissection of the C-terminal domain of type II DNA topoisomerase from the kinetoplastid hemoflagellate Leishmania donovani.

Authors:  Tanushri Sengupta; Mandira Mukherjee; Chhabinath Mandal; Aditi Das; Hemanta K Majumder
Journal:  Nucleic Acids Res       Date:  2003-09-15       Impact factor: 16.971

9.  Granzyme M targets topoisomerase II alpha to trigger cell cycle arrest and caspase-dependent apoptosis.

Authors:  S A H de Poot; K W Lai; L van der Wal; K Plasman; P Van Damme; A C Porter; K Gevaert; N Bovenschen
Journal:  Cell Death Differ       Date:  2013-11-01       Impact factor: 15.828

10.  Cloning, functional analysis and post-transcriptional regulation of a type II DNA topoisomerase from Leishmania infantum. A new potential target for anti-parasite drugs.

Authors:  Tobias Hanke; María J Ramiro; Sonia Trigueros; Joaquim Roca; Vicente Larraga
Journal:  Nucleic Acids Res       Date:  2003-08-15       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.